PROTECT MULTI AKTIENANLEIHE - NOVARTIS N/BIONTECH ADR/ROCHE GS Share Price

Certificat

DE000VU9QMQ6

Market Closed - Deutsche Boerse AG 11:31:07 10/05/2024 pm IST
100.2 EUR +0.23% Intraday chart for PROTECT MULTI AKTIENANLEIHE - NOVARTIS N/BIONTECH ADR/ROCHE GS
Current month+0.86%
1 month+1.79%
Date Price Change Volume
10/24/10 100.2 +0.23% 0
09/24/09 99.93 -0.08% 0
08/24/08 100 +0.08% 0
07/24/07 99.93 0.00% 0
06/24/06 99.93 +0.02% 0

Delayed Quote Deutsche Boerse AG

Last update May 10, 2024 at 11:31 pm IST

More quotes

Static data

Product typeAktienanleihen
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WKN VU9QMQ
ISINDE000VU9QMQ6
Date issued 24/07/2023
Strike 273.5 CHF
Maturity 21/06/2024 (41 Days)
Parity 0.27 : 1
Emission price 100
Emission volume N/A
Settlement Beides
Currency EUR

Technical Indicators

Highest since issue 101.8
Lowest since issue 88.22

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
225.1 CHF
Average target price
279.4 CHF
Spread / Average Target
+24.12%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW